Biblio

Export 125 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Biomarkers  [Clear All Filters]
2022
L. Chen, Shen, Q., Xu, S., Yu, H., Pei, S., Zhang, Y., He, X., Wang, Q. Z., and Li, D., 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.
S. J. Teipel, Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N. - C., Dechent, P., Dobisch, L., Düzel, E., Ewers, M., Fliessbach, K., Haynes, J. D., Janowitz, D., Kilimann, I., Laske, C., Maier, F., Metzger, C. D., Munk, M. H., Peters, O., Pomara, N., Preis, L., Priller, J., Rámirez, A., Roy, N., Scheffler, K., Schneider, A., Schott, B. H., Spottke, A., Spruth, E. J., Wagner, M., Wiltfang, J., Jessen, F., and Heneka, M. T., Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum., J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
D. R. Galasko, Grill, J. D., Lingler, J. H., and Heidebrink, J. L., A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?, J Alzheimers Dis, vol. 90, no. 3, pp. 963-966, 2022.
T. K. Karikari, Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance., J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
S. Tok, Ahnaou, A., and Drinkenburg, W., Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression., J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
S. Hannonen, Andberg, S., Kärkkäinen, V., Rusanen, M., Lehtola, J. - M., Saari, T., Korhonen, V., Hokkanen, L., Hallikainen, M., Hänninen, T., Leinonen, V., Kaarniranta, K., Bednarik, R., and Koivisto, A. M., Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
J. Lynn, Park, M., Ogunwale, C., and Acquaah-Mensah, G. K., A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
2021
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid., J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B., Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals., J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
S. Toniolo, Scarioni, M., Di Lorenzo, F., Hort, J., Georges, J., Tomic, S., Nobili, F., and Frederiksen, K. Steen, Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care., J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid., J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
S. Toniolo, Di Lorenzo, F., Scarioni, M., Frederiksen, K. Steen, and Nobili, F., Is the Frontal Lobe the Primary Target of SARS-CoV-2?, J Alzheimers Dis, vol. 81, no. 1, pp. 75-81, 2021.
X. - L. Ding, Tuo, Q. - Z., and Lei, P., An Introduction to Ultrasensitive Assays for Plasma Tau Detection., J Alzheimers Dis, vol. 80, no. 4, pp. 1353-1362, 2021.
L. Guzmán-Martínez, Calfío, C., Farías, G. A., Vilches, C., Prieto, R., and Maccioni, R. B., New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
W. Wu, Lee, I., Spratt, H., Fang, X., and Bao, X., tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms., J Alzheimers Dis, vol. 79, no. 2, pp. 793-806, 2021.
S. Merighi, Battistello, E., Casetta, I., Gragnaniello, D., Poloni, T. Emanuele, Medici, V., Cirrincione, A., Varani, K., Vincenzi, F., Borea, P. Andrea, and Gessi, S., Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 1105-1117, 2021.
2018
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset., J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
H. - H. Tsou, Hsu, W. - C., Fuh, J. - L., Chen, S. - P., Liu, T. - Y., and Wang, H. - T., Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 571-580, 2018.
C. - C. Yang, Chiu, M. - J., Chen, T. - F., Chang, H. - L., Liu, B. - H., and Yang, S. - Y., Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1323-1332, 2018.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N., Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β., J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
D. - W. Chen, Wang, J., Zhang, L. - L., Wang, Y. - J., and Gao, C. - Y., Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia., J Alzheimers Dis, vol. 61, no. 2, pp. 645-651, 2018.
A. Kimura, Yoshikura, N., Hayashi, Y., and Inuzuka, T., Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 581-588, 2018.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.

Pages